Guangxi Xianzhu Pharmaceutical Co., Ltd. announced that it will raise CNY 50 million in an equity funding on May 31, 2024. The transaction will include participation from new investor,Guangxi LiuYao Group Co., Ltd. The transaction has been approved at the 16th meeting of the 5th Board of Directors and the 13th meeting of the 5th Board of Supervisors. Upon the closing, the company's registered capital will increased from CNY 50 million to CNY 100 million.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.5 CNY | +0.11% | -2.94% | -7.51% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.51% | 960M | |
-2.46% | 23.95B | |
+14.23% | 8.7B | |
+1.47% | 8.29B | |
-32.92% | 6.7B | |
+18.62% | 5.38B | |
+1.10% | 4.08B | |
-9.24% | 3.79B | |
-10.20% | 3.3B | |
+7.58% | 3.2B |
- Stock Market
- Equities
- 603368 Stock
- News Guangxi LiuYao Group Co., Ltd
- Guangxi Xianzhu Pharmaceutical Co., Ltd. announced that it expects to receive CNY 50 million in funding from Guangxi LiuYao Group Co., Ltd